M. Lee

发表

Dose‐independent pharmacokinetics of torasemide after intravenous and oral administration to rats

Ji Young Kim, D. Y. Lee, Yu C. Kim, 2005, Biopharmaceutics & drug disposition.

Pharmacokinetic changes of DA-7867, a new oxazolidinone, after intravenous and oral administration to rats with short-term and long-term diabetes mellitus induced by streptozotocin.

J. Kwon, Won Bae Kim, M. Lee, 2005, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

Pharmacokinetic interaction between liquiritigenin (LQ) and DDB: increased glucuronidation of LQ in the liver possibly due to increased hepatic blood flow rate by DDB.

M. Lee, Hye J. Chung, H. Kang, 2010, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

Interspecies pharmacokinetic scaling of DA‐8159, a new erectogenic, in mice, rats, rabbits and dogs, and prediction of human pharmacokinetics

So H. Kim, Yu C. Kim, J. Kwon, 2005, Biopharmaceutics & drug disposition.

Effect of hepatic CYP inhibitors on the metabolism of sildenafil and formation of its metabolite, N‐desmethylsildenafil, in rats in vitro and in vivo

M. Lee, S. Bae, S. Bae, 2009, The Journal of pharmacy and pharmacology.

Pharmacokinetics and pharmacodynamics of furosemide in protein-calorie malnutrition

Y. Choi, So H. Kim, M. Lee, 1993, Journal of Pharmacokinetics and Biopharmaceutics.

Pharmacokinetics and pharmacodynamics of intravenous trasemide in mutant nagase aalbuminemic rats

E. J. Kim, M. Lee, 2003 .

The effect of intravenous infusion time on the pharmacokinetics and pharmacodynamics of the same total dose of azosemide in rabbits

W. Shin, M. Lee, W. Yoon, 1997 .

Pharmacokinetics of methotrexate after intravenous and intramuscular injection of methotrexate‐bearing positively charged liposomes to rats

Chong-K. Kim, Sung-Joo Hwang, Sun Hwa Lee, 1995 .

Pharmacokinetics of methotrexate after intravenous and intramuscular injection of methotrexate‐bearing neutral liposomes to rats

Chong-K. Kim, Sung-Joo Hwang, Sun Hwa Lee, 1993 .

Pharmacokinetics of methotrexate after intravenous infusion of methotrexate-rabbit serum albumin conjugate to rabbits

Chong-K. Kim, M. Lee, M. Park, 1991 .

Pharmacokinetics of oltipraz in mutant Nagase analbuminemic rats.

M. Lee, S. Bae, H. Kang, 2006, Journal of pharmaceutical sciences.

Effects of cysteine on the pharmacokinetics of oltipraz in rats with protein-calorie malnutrition.

J. Kwon, M. Lee, S. Bae, 2005, Journal of pharmaceutical sciences.

Effects of acute renal failure on the pharmacokinetics of oltipraz in rats.

Sang -Geon Kim, M. Lee, S. Bae, 2004, Journal of pharmaceutical sciences.

Pharmacokinetic changes of DA-8159, a new erectogenic, after intravenous and oral administration to rats with diabetes mellitus induced by streptozotocin.

Yu C. Kim, J. Kwon, Won Bae Kim, 2004, Journal of pharmaceutical sciences.

Pharmacokinetic changes of oltipraz after intravenous and oral administration to rats with liver cirrhosis induced by dimethylnitrosamine.

Sang -Geon Kim, M. Lee, S. Bae, 2004, International journal of pharmaceutics.

Effects of glucose on the pharmacokinetics of intravenous chlorzoxazone in rats with acute renal failure induced by uranyl nitrate.

E. J. Kim, Sang -Geon Kim, J. Kwon, 2003, Journal of pharmaceutical sciences.

Dose-dependent pharmacokinetics of human granulocyte/macrophage colony-stimulating factor in rabbits

Bhumsoo Kim, Sun Hwa Lee, M. Lee, 1993 .

Pharmacokinetics and therapeutic effects of oltipraz after consecutive or intermittent oral administration in rats with liver cirrhosis induced by dimethylnitrosamine.

Sang -Geon Kim, M. Lee, S. Bae, 2006, Journal of pharmaceutical sciences.

Pharmacokinetics of sildenafil after intravenous and oral administration in rats: hepatic and intestinal first-pass effects.

M. Lee, S. Bae, Hyun S. Shin, 2006, International journal of pharmaceutics.

Effects of omeprazole or cola beverage on the pharmacokinetics of oral DA-8159, a new erectogenic, in rats.

J. Kwon, Won Bae Kim, M. Lee, 2005, Biopharmaceutics & drug disposition.

Pharmacokinetic changes of DA‐8159, a new erectogenic, and one of its metabolites, DA‐8164 after intravenous and oral administration of DA‐8159 to spontaneously hypertensive rats and DOCA–salt‐induced hypertensive rats

Yu C. Kim, J. Kwon, Won Bae Kim, 2005, Biopharmaceutics & drug disposition.

Effects of enzyme inducers and inhibitors on the pharmacokinetics of intravenous DA‐8159, a new erectogenic, in rats

Yu C. Kim, J. Kwon, Won Bae Kim, 2005, Biopharmaceutics & drug disposition.

Pharmacokinetics of DA-8159, a new erectogenic, administered at 10:00 h versus 22:00 h in rats.

Yu C. Kim, J. Kwon, Won Bae Kim, 2005, International journal of pharmaceutics.

Pharmacokinetics of DA-8159, a new erectogenic, after intravenous and oral administration to rats: hepatic and intestinal first-pass effects.

Yu C. Kim, J. Kwon, Won Bae Kim, 2003, Journal of pharmaceutical sciences.

Pharmacokinetics of mirodenafil and Its two metabolites, SK3541 and SK3544, in spontaneously or DOCA–salt‐induced hypertensive rats

Y. Choi, M. Lee, Young S. Lee, 2011, Biopharmaceutics & drug disposition.

Pharmacokinetics and pharmacodynamics of bumetanide after intravenous and oral administration to spontaneously hypertensive rats and DOCA‐salt induced hypertensive rats

M. Lee, S. H. Lee, Kye S. Han, 1993, Biopharmaceutics & drug disposition.

DA-8159 : Erectogenic

Yu C. Kim, M. Lee, M. Yoo, 2005 .

Hepatic and intestinal first-pass effects of oltipraz in rats.

Sang -Geon Kim, M. Lee, S. Bae, 2005, Biopharmaceutics & drug disposition.

Species differences in the formation of DA-8164 after intravenous and/or oral administration of DA-8159, a new erectogenic, to mice, rats, rabbits, dogs and humans.

Yu C. Kim, J. Kwon, Won Bae Kim, 2005, Biopharmaceutics & drug disposition.

Excretion and metabolism of DA-7867, a new oxazolidinone, in rats.

E. J. Kim, J. Kwon, Won Bae Kim, 2005, Biopharmaceutics & drug disposition.

Pharmacokinetics and tissue distribution of a new carbapenem, DA‐1131, after intravenous administration to mice, rats, rabbits and dogs

So H. Kim, J. Kwon, M. Lee, 1998, Biopharmaceutics & drug disposition.

Antimicrobial activities of hydroxybiphenyl derivatives (I)

K. Bae, M. Lee, B. Yoo, 1985 .

Gender differences in the pharmacokinetics of DA-6034, a derivative of flavonoids, in rats.

J. Kwon, M. Lee, S. Bae, 2006, Biopharmaceutics & drug disposition.

The phenomenon and cause of the dose-dependent oral absorption of chlorothiazide in rats: Extrapolation to human data based on the body surface area concept

T. Prueksaritanont, W. L. Chiou, M. Lee, 1987, Journal of Pharmacokinetics and Biopharmaceutics.

Factors influencing the protein binding of azosemide using an equilibrium dialysis technique

M. Lee, S. H. Lee, 1995, Biopharmaceutics & drug disposition.

Pharmacokinetics of clarithromycin in rats with acute renal failure induced by uranyl nitrate

Sang -Geon Kim, So H. Kim, J. Kwon, 2004, Biopharmaceutics & drug disposition.

Effects of acute renal failure on the pharmacokinetics of telithromycin in rats: negligible effects of increase in CYP3A1 on the metabolism of telithromycin

M. Lee, Joo H. Lee, 2007, Biopharmaceutics & drug disposition.

Pharmacokinetics of L‐FMAUS, a new antiviral agent, after intravenous and oral administration to rats: contribution of gastrointestinal first‐pass effect to low bioavailability

M. Lee, Hye J. Chung, Joo H. Lee, 2007, Biopharmaceutics & drug disposition.

Pharmacokinetics of ciprofloxacin after intravenous administration of ciprofloxacin-TOF in rabbits

Sun Hwa Lee, M. Lee, S. Jang, 1994 .

Dose-independent pharmacokinetics of metformin in rats: Hepatic and gastrointestinal first-pass effects.

M. Lee, Sang Geon Kim, Young H. Choi, 2006, Journal of pharmaceutical sciences.

Effects of water deprivation for 72 hours on the pharmacokinetics of DA‐7867, a new oxazolidinone, in rats

Yu C. Kim, J. Kwon, M. Lee, 2006, Biopharmaceutics & drug disposition.

Effects of water deprivation on the pharmacokinetics and pharmacodynamics of bumetanide in rats

M. Lee, M. Lee, S. H. Lee, 1993, Biopharmaceutics & drug disposition.

Effects of water deprivation on the pharmacokinetics of theophylline and one of its metabolites, 1,3‐dimethyluric acid, after intravenous and oral administration of aminophylline to rats

M. Lee, S. Bae, Hye J. Chung, 2007, Biopharmaceutics & drug disposition.

Effects of water deprivation on the pharmacokinetics of metformin in rats

M. Lee, Young H. Choi, Inchul Lee, 2007, Biopharmaceutics & drug disposition.

Pharmacokinetics of omeprazole in rats with water deprivation for 72 hours

M. Lee, Hyun S. Shin, D. Lee, 2006, Biopharmaceutics & drug disposition.

Pharmacokinetics of oltipraz after intravenous and oral administration in rats with dehydration for 72 hours.

M. Lee, S. Bae, Shin Jung Lee, 2005, Biopharmaceutics & drug disposition.

Pharmacokinetics of intravenous chlorzoxazone in rats with dehydration and rehydration: effects of food intakes

E. J. Kim, Yu C. Kim, M. Lee, 2003, Biopharmaceutics & drug disposition.

Effects of acute renal failure induced by uranyl nitrate on the pharmacokinetics of liquiritigenin and its two glucuronides, M1 and M2, in rats

S. Sohn, S. Baek, M. Lee, 2011, The Journal of pharmacy and pharmacology.

Pharmacokinetics of liquiritigenin in mice, rats, rabbits, and dogs, and animal scale-up.

S. Sohn, So H. Kim, S. Baek, 2009, Journal of pharmaceutical sciences.

Time‐dependent effects of Klebsiella pneumoniae endotoxin on the pharmacokinetics of chlorzoxazone and its main metabolite, 6‐hydroxychlorzoxazone, in rats: restoration of the parameters in 96 hour in KPLPS rats to control levels

So H. Kim, M. Lee, H. Kang, 2009, Biopharmaceutics & drug disposition.

Pharmacokinetic Parameters of Chlorzoxazone and Its Main Metabolite, 6-Hydroxychlorzoxazone, after Intravenous and Oral Administration of Chlorzoxazone to Liver Cirrhotic Rats with Diabetes Mellitus

W. Shin, Young-Suk Jung, M. Lee, 2008, Drug Metabolism and Disposition.

Pharmacokinetics of chlorzoxazone in rats with diabetes: Induction of CYP2E1 on 6-hydroxychlorzoxazone formation.

M. Lee, S. Bae, Y. Sohn, 2006, Journal of pharmaceutical sciences.

Effects of bacterial lipopolysaccharide on the pharmacokinetics of metformin in rats.

M. Lee, Young H. Choi, Inchul Lee, 2007, International journal of pharmaceutics.

Pharmacokinetics of diclofenac in rat model of diabetes mellitus induced by alloxan or steptozotocin

So H. Kim, Yu C. Kim, M. Lee, 2006, Biopharmaceutics & drug disposition.

Factors influencing the protein binding of YH‐439 using an equilibrium dialysis technique. A new hepatoprotective agent

C. Shim, Joo-Heon Park, J. Lee, 1995, Biopharmaceutics & drug disposition.

Dose-independent pharmacokinetics of recombinant human interferon-αA in rabbits

Sun Hwa Lee, M. Lee, S. Jang, 1992 .

Pharmacokinetics and pharmacodynamics of azosemide

So H. Kim, M. Lee, So H Kim, 2003, Biopharmaceutics & drug disposition.

Circadian Changes in the Pharmacokinetics and Pharmacodynamics of Azosemide in Rats

M. Lee, Kye S. Han, 1998, The Journal of pharmacy and pharmacology.

Effects of sodium thiosulfate on the pharmacokinetics of total platinum after intravenous administration of cisplatin to rabbits

M. Lee, E. Yoon, S. H. Kim, 1993 .

Dose‐independent pharmacokinetics of ondansetron in rats: contribution of hepatic and intestinal first‐pass effects to low bioavailability

M. Lee, Si-hyung Yang, 2008, Biopharmaceutics & drug disposition.

The pharmacokinetics of methotrexate after intravenous administration of methotrexate‐loaded proliposomes to rats

J. M. Park, C. Shim, M. Lee, 1994, Biopharmaceutics & drug disposition.

Gastrointestinal First‐pass Effect of YJA‐20379‐8, a New Reversible Proton Pump Inhibitor, in Rats

Jonghan Kim, M. Lee, M. Lee, 1999, The Journal of pharmacy and pharmacology.

Stability, tissue metabolism, tissue distribution and blood partition of azosemide

M. Lee, M. Lee, S. H. Lee, 1995, Biopharmaceutics & drug disposition.

Effects of E. Coli lipopolysaccharide on the pharmacokinetics of ipriflavone and its metabolites, M1 and M5, after intravenous and oral administration of ipriflavone to rats: decreased metabolism of ipriflavone due to decreased expression of hepatic CYP1A2 and 2C11.

M. Lee, Sang Geon Kim, Hye J. Chung, 2008, Journal of pharmaceutical sciences.

Effects of bacterial lipopolysaccharide on the pharmacokinetics of DA-7867, a new oxazolidinone, in rats.

J. Kwon, Won Bae Kim, M. Lee, 2004, Journal of pharmaceutical sciences.

Effects of acute renal failure on the pharmacokinetics of DA‐7867, a new oxazolidinone, in rats

J. Kwon, Won Bae Kim, M. Lee, 2006, Biopharmaceutics & drug disposition.

Pharmacokinetics, blood partition and protein binding of DA‐7867, a new oxazolidinone

E. J. Kim, J. Kwon, Won Bae Kim, 2004, Biopharmaceutics & drug disposition.

Dose-independent pharmacokinetics of a new neuroprotective agent for ischemia-reperfusion damage, KR-31543, after intravenous and oral administration to rats: hepatic and intestinal first-pass effects.

E. J. Kim, S. Yoo, Myung G. Lee, 2003, Journal of pharmaceutical sciences.

Pharmacokinetic and pharmacodynamic changes of furosemide after intravenous and oral administration to rats with alloxan‐induced diabetes mellitus

M. Lee, W. Yoon, Jung‐S. Lee, 1998, Biopharmaceutics & drug disposition.

Pharmacokinetics of a new carbapenem, DA‐1131, after intravenous administration to rats with alloxan‐induced diabetes mellitus

So H. Kim, Won Bae Kim, M. Lee, 1998, Biopharmaceutics & drug disposition.

Pharmacokinetics and Pharmacodynamics of Azosemide after Intravenous and Oral Administration to Rats with Alloxan‐induced Diabetes Mellitus

W. Shin, M. Lee, W. Yoon, 1996, The Journal of pharmacy and pharmacology.

Pharmacokinetics of amitriptyline and one of its metabolites, nortriptyline, in rats: little contribution of considerable hepatic first-pass effect to low bioavailability of amitriptyline due to great intestinal first-pass effect.

Dipendra K. Aryal, M. Lee, S. Bae, 2009, Journal of pharmaceutical sciences.

Liquiritigenin pharmacokinetics in a rat model of diabetes mellitus induced by streptozotocin: greater formation of glucuronides in the liver, especially M2, due to increased hepatic uridine 5'-diphosphoglucuronic acid level.

S. Sohn, S. Baek, M. Lee, 2010, Metabolism: clinical and experimental.

Pharmacokinetics and tissue distribution of adriamycin and adriamycinol after intravenous administration of adriamycin-loaded neutral proliposomes to rats

W. Paik, C. Shim, M. Lee, 1995 .

Effect of intravenous infusion time on the pharmacokinetics and pharmacodynamics of the same total dose of bumetanide

M. Lee, M. Lee, S. H. Ryoo, 1986, Biopharmaceutics & drug disposition.

Pharmacokinetics of intravenous methotrexate in mutant Nagase analbuminemic rats

M. Lee, S. Bae, Sun‐Ok Kim, 2007, Biopharmaceutics & drug disposition.

Ipriflavone pharmacokinetics in mutant Nagase analbuminemic rats

M. Lee, Hye J. Chung, Kyung H. Yang, 2009, Biopharmaceutics & drug disposition.

Effects of phenobarbital and 3‐methylcholanthrene pretreatment on the pharmacokinetics and the pharmacodynamics of bumetanide in rats

M. Lee, S. Jang, S. H. Lee, 1991, Biopharmaceutics & drug disposition.

Pharmacokinetics and pharmacodynamics of intravenous torasemide in diabetic rats induced by alloxan or streptozotocin

So H. Kim, Yu C. Kim, M. Lee, 2005, Biopharmaceutics & drug disposition.

Effects of enzyme inducers and inhibitors on the pharmacokinetics of intravenous torasemide in rats.

M. Lee, Shin Jung Lee, D. Lee, 2005, International journal of pharmaceutics.

Faster clearance of mirodenafil in rats with acute renal failure induced by uranyl nitrate: contribution of increased protein expression of hepatic CYP3A1 and intestinal CYP1A1 and 3A1/2

M. Lee, Young S. Lee, Young H. Choi, 2009 .

Effects of cysteine on metformin pharmacokinetics in rats with protein‐calorie malnutrition: partial restoration of some parameters to control levels

M. Lee, Young H. Choi, Inchul Lee, 2008, The Journal of pharmacy and pharmacology.

Effects of cysteine on the pharmacokinetic parameters of omeprazole in rats with protein-calorie malnutrition: partial restoration of some parameters to control levels by oral cysteine supplementation.

M. Lee, D. Lee, Inchul Lee, 2007, JPEN. Journal of parenteral and enteral nutrition.

Pharmacokinetics and pharmacodynamics of furosemide after intravenous and oral administration to spontaneously hypertensive rats and DOCA‐salt‐induced hypertensive rats

M. Lee, S. Jang, Nak D. Kim, 1994, Biopharmaceutics & drug disposition.

Factors influencing the protein binding of vancomycin

N. D. Kim, W. Shin, M. Lee, 1991, Biopharmaceutics & drug disposition.

Changes in metformin pharmacokinetics after intravenous and oral administration to rats with short-term and long-term diabetes induced by streptozotocin.

M. Lee, Young H. Choi, Inchul Lee, 2008, Journal of pharmaceutical sciences.

Pharmacokinetic changes of ipriflavone in rats with acute renal failure induced by uranyl nitrate.

M. Lee, Hye J. Chung, 2006, Biopharmaceutics & drug disposition.

Pharmacokinetics and tissue distribution of ipriflavone, an isoflavone derivative, after intravenous administration to rabbits

So H. Kim, M. Lee, J. S. Lee, 2000, Biopharmaceutics & drug disposition.

Pharmacokinetics of phenytoin and its metabolite, 4′‐HPPH, after intravenous and oral administration of phenytoin to diabetic rats induced by alloxan or streptozotocin

Yu C. Kim, M. Lee, H. Kang, 2008, Biopharmaceutics & drug disposition.

Pharmacokinetics of a New Proton‐pump Inhibitor, YJA‐20379‐8, after Intravenous and Oral Administration to Rats with Streptozotocin‐induced Diabetes Mellitus

M. Lee, S. Y. Chung, Kye S. Han, 1999, The Journal of pharmacy and pharmacology.

Comparison of potential bone pain palliation agents — Lu-177-EDTMP and Lu-177-DOTMP

D. Lee, Y. Chang, Yun-Sang Lee, 2008 .

Interspecies pharmacokinetic scaling of a new carbapenem, DA‐1131, in mice, rats, rabbits and dogs, and prediction of human pharmacokinetics

So H. Kim, Won Bae Kim, M. Lee, 1998, Biopharmaceutics & drug disposition.

Pharmacokinetics of a new reversible proton pump inhibitor, YH1885, after intravenous and oral administrations to rats and dogs: hepatic first‐pass effect in rats

M. Lee, Yoon G Kim, Kye S. Han, 1998, Biopharmaceutics & drug disposition.

Pharmacokinetics of FT-ADM after intravenous administration of DA-125, a prodrug of FT-ADM or FT-ADM to rats. A new adriamycin analog containing fluorine

Won Bae Kim, M. Lee, H. Shim, 1994 .

Pharmacokinetics, tissue distribution and biliary excretion of FT-ADM after intravenous administration of DA-125, a prodrug of FT-ADM to dogs. A new adriamycin analog containing fluorine

Won Bae Kim, M. Lee, W. Yoon, 1994 .

FACTORS INFLUENCING THE PROTEIN DIALYSIS TECHNIQUE. A NEW HEPATOPROTECTIVE AGENT BINDING OF YH-439 USING AN EQUILIBRIUM

C. Shim, M. Lee, W. Yoon, 2005 .

Pharmacokinetics of 5-fluorouracil in rats with diabetes mellitus induced by streptozotocin.

S. O. Kim, M. Lee, S. Bae, 2005, Biopharmaceutics & drug disposition.

Time-Dependent Effects of Klebsiella Pneumoniae Endotoxin (KPLPS) on the Pharmacokinetics of Theophylline in Rats: Return of the Parameters in 96-Hour KPLPS Rats to the Control Levels

Young C. Kim, Young-Suk Jung, M. Lee, 2008, Drug Metabolism and Disposition.

Pharkacokinetics and pharmacodynamics of furosemide after direct administration into the stomach or duodenum

W. Shin, M. Lee, W. Yoon, 1997 .

Effects of CYP inducers and inhibitors on the pharmacokinetics of intravenous theophylline in rats: involvement of CYP1A1/2 in the formation of 1,3‐DMU

M. Lee, Kyung H Yang, Joo H Lee, 2008, The Journal of pharmacy and pharmacology.

Electron-beam assisted growth of hexagonal boron-nitride layer

J. Kwon, Y. Song, S. Lim, 2013 .

Gastrointestinal Absorption of a New Reversible Proton Pump Inhibitor, YJA‐20379‐8, and its Pharmacokinetics after Oral Administration in Acetic Acid‐induced Gastric Ulcer in Rats

Jonghan Kim, M. Lee, Kye S. Han, 1999, The Journal of pharmacy and pharmacology.

Changes in metformin pharmacokinetics after intravenous and oral administration to rats with short-term and long-term diabetes induced by streptozotocin.

M. Lee, Young H. Choi, Inchul Lee, 2008, Journal of pharmaceutical sciences.

Renal and non-renal clearances of iothalamate.

T. Prueksaritanont, W. L. Chiou, M. Lee, 1986, Biopharmaceutics & drug disposition.

Pharmacokinetics of 5‐fluorouracil in mutant Nagase analbuminemic rats: faster metabolism of 5‐fluorouracil via CYP1A

M. Lee, S. Bae, Young H. Choi, 2007, Biopharmaceutics & drug disposition.

Effects of the rate and composition of fluid replacement on the pharmacokinetics and pharmacodynamics of intravenous azosemide

M. Lee, W. Yoon, Kwang J. Park, 1997, Biopharmaceutics & drug disposition.

Dose‐independent pharmacokinetics of ondansetron in rats: contribution of hepatic and intestinal first‐pass effects to low bioavailability

M. Lee, Si-hyung Yang, 2008, Biopharmaceutics & drug disposition.